Dr. Amy DeZern is a hematologist and Professor of Oncology and Medicine at the Johns Hopkins University School of Medicine. Dr. DeZern’s primary clinical and research interests are focused on bone marrow failure disorders. She has expertise in the diagnosis and treatment of aplastic anemia (AA), myelodysplastic syndromes (MDS), clonal hematopoiesis (CH), and paroxysmal nocturnal hemoglobinuria (PNH) as well as acute leukemias. She is an active clinician-scientist who specializes in clinical trials of diagnostics and therapeutics for these disorders. She has been the principal investigator for over 40 single-center and multicenter clinical trials in MDS and AA. These investigator-led initiatives focus on transplant therapies in AA (including the upcoming BMT CTN upfront trial for SAA) and novel therapeutics (Phase 1-3 trials) in MDS. Additionally, Dr. DeZern is the deputy co-chair of The National MDS Study.